ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,588.27
      -1.39%
      US Tech 100
      19,336.00
      -2.61%
      Dow Jones
      41,198.08
      0.59%
      Brent Oil
      84.675
      0.22%
      Bitcoin
      64,531.37
      0.70%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. PharmaCyte Biotech Inc (PMCB)

      7. PharmaCyte Biotech Inc (PMCB) Financials

      PharmaCyte Biotech Inc

      PharmaCyte Biotech Inc (PMCB)

      NASDAQ
      2.06
      0.01
      (0.49%)
      Closed July 17 4:00PM
      Delayed by 15 minutes
      2.06
      0.00
      (0.00%)
      After Hours: 5:16PM
      Delayed by 15 minutes

      PharmaCyte Biotech Inc Financial Summary

      The current PMCB market cap is 17.44M. The company's latest EPS is USD -0.5099 and P/E is -4.04.

      Income Statement

      Annual Quarterly
      Quarter End Jan 2023Apr 2023Jul 2023Oct 2023Jan 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -1.55M-902k-2.08M-1.41M-1.87M
      Net Income -764k-126k-3.5M-5.53M-5.66M
      Year End April 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -4.1M-3.83M-3.62M-4.39M-6.46M
      Net Income -4.07M-3.83M-3.55M-4.24M-4.32M

      Balance Sheet

      Annual Quarterly
      Quarter End Jan 2023Apr 2023Jul 2023Oct 2023Jan 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 77.95M73.28M79.88M78.88M71.36M
      Total Liabilities 828k587k20.4M20.81M22.47M
      Total Equity 77.12M72.69M42.73M36.77M31.38M
      Year End April 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 5.78M6.17M7.4M90.62M73.28M
      Total Liabilities 742k1.08M725k704k587k
      Total Equity 5.04M5.09M6.68M89.92M72.69M

      Cash Flow

      Annual Quarterly
      Quarter End Jan 2023Apr 2023Jul 2023Oct 2023Jan 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -3.51M-3.79M344k-1.64M-1.82M
      Investing N/A N/A N/A N/A -5M
      Financing -9.25M-13.56M6.28M7.03M-11k
      Year End April 29 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -2.88M-2.34M-3.33M-4.12M-3.79M
      Investing N/A N/A N/A N/A N/A
      Financing 2.34M2.73M4.64M87.31M-13.56M

      Stats and Ratios

      Market Cap 17.44M
      Price to Earnings Ratio -4.04
      Price to Sales Ratio 0
      Price to Cash Ratio 0.26
      Price to Book Ratio 0.24
      Dividend Yield -

      Share Statistics

      Shares Outstanding 8.46M
      Average Volume (1 week) 10.01k
      Average Volume (1 Month) 10.6k
      52 Week Change -26.43%
      52 Week High 2.8999
      52 Week Low 1.76
      Spread (Intraday) 0.41 (17.45%)

      Company Info

      Company Name PharmaCyte Biotech Inc
      Address 401 ryland st ste 200-a
      reno, nevada 89502
      Website https://ir.pharmacyte.com
      Industry medicinal chems,botanicl pds (2833)